From: Mitochondrial mutations and metabolic adaptation in pancreatic cancer
Cell line | ChrM position | Normal | Tumour | Cell line | AA change | Region | ETC complex | Literature |
---|---|---|---|---|---|---|---|---|
TKCC-02 | 13,195–14,000 | cons | 2 bp del | 2 bp del | Frameshift | ND5 | I | Similar region- colorectal cancer: Polyak 1998 |
TKCC-03 | 310 | C/T | T | T | - | HVSII | - | Â |
 | 311 | C/T | C | C | - | HVSII | - |  |
 | 8276.3–8276.4 | CC ins | :: | :: | - | NC7 | - |  |
 | 15,692–15,694 | ATA | ::: del | ::: del | M316Δ | CytB | III | T15693C LVNC cardiomyopathy: Tang 2010 |
TKCC-04 | 15,873 | T | - | C/T | M376T | CytB | III | NOVEL |
TKCC-07 | 309.3 | : | - | C ins | - | HVSII | - | Alzheimer’s: Tanaka 2010 |
 | 4971 | G | - | A | G168S | ND2 | I | NOVEL |
 | 7211 | G | - | A | M436M | COI | IV |  |
 | 11,361 | T | - | C | M201T | ND4 | I |  |
 | 12,731 | T | - | C | V132A | ND5 | I | NOVEL |
 | 13,579 | G | - | A | A415T | ND5 | I | NOVEL |
 | 14,207 | G (C reverse) | - | A (T reverse) | T156I | ND6 | I |  |
 | 16,092 | C | - | T | - | HVSI | - |  |
TKCC-09 | 4137 | C | T | T | Y277Y | NDI | I | Â |
 | 16,188.1 | : | : | C ins | - | HVSI | - |  |
TKCC-10 | 438 | C | C/T | T | - | L strand promoter | - | Â |
TKCC-15-LO | 4560 | G | - | C/g | W30S | ND2 | I | NOVEL |
TKCC-16-LO | 14,686 | G | - | G/a | - | TE (tRNA) | - | NOVEL |
TKCC-17-LO | 6029 | C | - | T/c | G42G | COI | IV | Â |
TKCC-18-LO | 15,557 | G | - | A | Q271K | CytB | III | NOVEL |
 | 16,126 | C | - | T (wt ref. seq) | - | HVSI | - | Glioblastoma T > C Kirches 2001, Brandon 2006 |
TKCC-19-LO | 309.1–309.2 | C | CC | CC | - | HVSII | - |  |
TKCC-26-LO | 12,508 | G | - | A | P58N | ND5 | I | NOVEL |